Logo image of CLE.MI

CLASS EDITORI SPA (CLE.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:CLE - IT0005117848 - Common Stock

0.1515 EUR
0 (-0.33%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

2

Overall CLE gets a fundamental rating of 2 out of 10. We evaluated CLE against 67 industry peers in the Media industry. Both the profitability and financial health of CLE have multiple concerns. CLE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CLE has reported negative net income.
In the past year CLE had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLE reported negative net income in multiple years.
In multiple years CLE reported negative operating cash flow during the last 5 years.
CLE.MI Yearly Net Income VS EBIT VS OCF VS FCFCLE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

The Return On Assets of CLE (-1.81%) is worse than 72.73% of its industry peers.
CLE has a Return On Equity of -47.04%. This is in the lower half of the industry: CLE underperforms 77.27% of its industry peers.
CLE has a worse Return On Invested Capital (2.24%) than 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLE is above the industry average of 7.95%.
The last Return On Invested Capital (2.24%) for CLE is well below the 3 year average (10.13%), which needs to be investigated, but indicates that CLE had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.81%
ROE -47.04%
ROIC 2.24%
ROA(3y)2.82%
ROA(5y)-1.7%
ROE(3y)44.72%
ROE(5y)N/A
ROIC(3y)10.13%
ROIC(5y)N/A
CLE.MI Yearly ROA, ROE, ROICCLE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

With a Operating Margin value of 3.14%, CLE perfoms like the industry average, outperforming 40.91% of the companies in the same industry.
Looking at the Gross Margin, with a value of 69.96%, CLE is in the better half of the industry, outperforming 69.70% of the companies in the same industry.
CLE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.14%
PM (TTM) N/A
GM 69.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y2.46%
CLE.MI Yearly Profit, Operating, Gross MarginsCLE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLE is creating some value.
Compared to 1 year ago, CLE has about the same amount of shares outstanding.
Compared to 5 years ago, CLE has more shares outstanding
Compared to 1 year ago, CLE has a worse debt to assets ratio.
CLE.MI Yearly Shares OutstandingCLE.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CLE.MI Yearly Total Debt VS Total AssetsCLE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -0.67, we must say that CLE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.67, CLE is doing worse than 83.33% of the companies in the same industry.
The Debt to FCF ratio of CLE is 6.03, which is on the high side as it means it would take CLE, 6.03 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.03, CLE is in line with its industry, outperforming 51.52% of the companies in the same industry.
A Debt/Equity ratio of 5.21 is on the high side and indicates that CLE has dependencies on debt financing.
CLE's Debt to Equity ratio of 5.21 is on the low side compared to the rest of the industry. CLE is outperformed by 84.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.21
Debt/FCF 6.03
Altman-Z -0.67
ROIC/WACC0.38
WACC5.88%
CLE.MI Yearly LT Debt VS Equity VS FCFCLE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

CLE has a Current Ratio of 0.64. This is a bad value and indicates that CLE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CLE (0.64) is worse than 75.76% of its industry peers.
CLE has a Quick Ratio of 0.64. This is a bad value and indicates that CLE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CLE (0.63) is worse than 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.63
CLE.MI Yearly Current Assets VS Current LiabilitesCLE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

CLE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -381.08%.
The Revenue has decreased by -0.71% in the past year.
CLE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.70% yearly.
EPS 1Y (TTM)-381.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.89%
Revenue 1Y (TTM)-0.71%
Revenue growth 3Y5.52%
Revenue growth 5Y0.7%
Sales Q2Q%3.71%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLE.MI Yearly Revenue VS EstimatesCLE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLE.MI Price Earnings VS Forward Price EarningsCLE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CLE.
Based on the Price/Free Cash Flow ratio, CLE is valued a bit cheaper than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.98
EV/EBITDA 7.66
CLE.MI Per share dataCLE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CLE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CLASS EDITORI SPA

BIT:CLE (1/9/2026, 7:00:00 PM)

0.1515

0 (-0.33%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners76.14%
Ins Owner ChangeN/A
Market Cap48.89M
Revenue(TTM)75.85M
Net Income(TTM)-2.88M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.64
P/FCF 7.98
P/OCF 5.04
P/B 7.97
P/tB N/A
EV/EBITDA 7.66
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY12.54%
OCF(TTM)0.03
OCFY19.84%
SpS0.24
BVpS0.02
TBVpS-0.2
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.81%
ROE -47.04%
ROCE 3.78%
ROIC 2.24%
ROICexc 2.34%
ROICexgc N/A
OM 3.14%
PM (TTM) N/A
GM 69.96%
FCFM 8.08%
ROA(3y)2.82%
ROA(5y)-1.7%
ROE(3y)44.72%
ROE(5y)N/A
ROIC(3y)10.13%
ROIC(5y)N/A
ROICexc(3y)10.66%
ROICexc(5y)N/A
ROICexgc(3y)81.76%
ROICexgc(5y)N/A
ROCE(3y)15.71%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y2.46%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 5.21
Debt/FCF 6.03
Debt/EBITDA 3.38
Cap/Depr 50.47%
Cap/Sales 4.71%
Interest Coverage 250
Cash Conversion 102.6%
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.63
Altman-Z -0.67
F-Score5
WACC5.88%
ROIC/WACC0.38
Cap/Depr(3y)66.6%
Cap/Depr(5y)71.2%
Cap/Sales(3y)6.36%
Cap/Sales(5y)7.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-381.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.71%
Revenue growth 3Y5.52%
Revenue growth 5Y0.7%
Sales Q2Q%3.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.3%
OCF growth 3YN/A
OCF growth 5YN/A

CLASS EDITORI SPA / CLE.MI FAQ

What is the ChartMill fundamental rating of CLASS EDITORI SPA (CLE.MI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLE.MI.


Can you provide the valuation status for CLASS EDITORI SPA?

ChartMill assigns a valuation rating of 1 / 10 to CLASS EDITORI SPA (CLE.MI). This can be considered as Overvalued.


Can you provide the profitability details for CLASS EDITORI SPA?

CLASS EDITORI SPA (CLE.MI) has a profitability rating of 3 / 10.


What is the financial health of CLASS EDITORI SPA (CLE.MI) stock?

The financial health rating of CLASS EDITORI SPA (CLE.MI) is 1 / 10.